Turning Complex Clinical Challenges Into Scalable Diagnostic Solutions

Owned portfolio strategy for autoimmune and infectious disease immunoassays. Partnered with R&D and regulatory teams to guide new product development, enhance assay performance, and deliver solutions aligned with market needs. Supported verification/validation activities and cross-functional risk analysis to ensure high clinical reliability.
Played a key role in rapid U.S. expansion of EUROIMMUN’s immunology products, growing market presence through clinician training, VOC initiatives, and targeted collaboration with key laboratories. Helped improve assay usability and customer satisfaction during a period of significant growth.